Joy Gibson, MD, PhD

Assistant Professor of Clinical Pediatrics

Image of Joy Gibson, MD, PhD
Is this your profile? Click to edit


Dr. Gibson’s laboratory seeks to optimize treatment regimens for challenging infections. Our primary focus is management of drug-resistant bacterial infections in cystic fibrosis, particularly non-tuberculous mycobacteria. We utilize a hollow fiber infection model to optimize current therapeutics and test novel treatment approaches in vitro.


  • Transcriptome profiles of macrophages upon infection by morphotypic smooth and rough variants of Mycobacterium abscessus Microbes Infect. 2024 May 22; 105367. . View in PubMed
  • Time-dependent pharmacodynamics of amikacin on Mycobacterium abscessus growth and resistance emergence Microbiol Spectr. 2024; 12(2). . View in PubMed
  • Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence Microbiol Res. 2021 Dec; 253:126887. . View in PubMed